African swine fever and classical swine fever are contagious viral diseases of pigs. These diseases are clinically identical and are difficult to distinguish, whereas they are caused due to unrelated viruses. Classical swine fever is also called as ‘hog cholera’ and it is caused due to a virus belonging to the Flaviviridae family. However, the virus causing African swine fever is unrelated to the other and it has more complex genetic makeup. Humans and other animals except pigs are not affected by these viruses.
Global Swine Fever Vaccine Market is forecast to exhibit a CAGR of 5.9% over the forecast period.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5195
Impact of COVID-19:
The pandemic has affected the financial status in several nations around the world in all sectors. The pandemic impacted the supply chain of the healthcare industry and this was mainly due to lockdowns imposed in many regions. Private healthcare has also been impacted due to the pandemic.
The pandemic had a negative impact on the global swine fever vaccine market, due to the reduced challenges related to transportation and reduced access to veterinarians. For instance, the National Center for Biotechnology Information published an article in September 2020, stated that limited access to veterinarians and issues related to transportation of animals during the time of need has resulted in high morbidity of diseases and also caused animal deaths.
Furthermore, increasing grants from various governments and research foundations to major players for developing swine fever vaccines is estimated to propel growth of the global swine fever vaccine market over the forecast period. For instance, Genvax Technologies received a grant of US$ 145,000 from the Foundation for Food & Agriculture Research for developing self-amplifying messenger RNA (saRNA) vaccine for African swine fever in in April 2022. This vaccine will be developed in collaboration with the USDA-ARS-PIADC (United States Department of Agriculture-Agricultural Research Services-Plum Island Animal Disease Center).
Rising funding from several non-government and government organizations is estimated to create awareness regarding swine fever which is anticipated to boost growth of the global swine fever vaccine market during the forecast period. For instance, a partnership between animal agriculture industry groups, Michigan State University and the Michigan Department of Agriculture & Rural Development was aiming to advance the animal agriculture economy around the state and they invested almost US$ 2.3 million in 26 new research projects in June 2022. One of the projects was assisting producers in preventing and responding to outbreak of diseases like African swine fever and avian influenza. The project will be supporting an expert team in preparing for outbreak of a disease, track biosecurity plans, produce educational materials and also provide verification.
- The global swine fever vaccine market is estimated to exhibit a CAGR of 5.9% over the forecast period, owing to rising outbreaks and increasing incidences of swine fever. For instance, Springer Nature Limited, published an article in September 2021, estimated the losses occurred due to African swine fever outbreak in China during August 2018 and July 2019. The results predicted that till July 2019, around 162 ASF outbreaks took place in China and 13,355 pigs died by the mid 2019 owing to African swine fever and almost 1,204,281 pigs were killed for stopping the transmission of the infection.
- The private segment, among distribution channels is estimated to witness robust growth in the global swine fever vaccine market during the forecast period, due to rise in adoption strategies like commercialization agreements and distribution by key players. For instance, a biopharmaceutical company, PlantForm and POSCO International which is a trading company based in South Korea, signed a signed a commercialization agreement in October 2021, for bringing HERBAVAC, which is the first plant-based vaccine for classical swine fever in the world. According to the agreement, PlantForm will receive exclusive rights for importing, selling, marketing and distributing HERBAVAC in the U.S., Canada, Mexico, Argentina and Brazil.
- North America, on the basis of region is anticipated to witness robust growth in the global swine fever vaccine market during the forecast period, due to rising funding from government organization for developing vaccines for swine fever. For instance, the US Department of Agriculture awarded with a funding of US$ 385,000 to the American Type Culture Collection, in April 2022. This funding was provided for two projects, one of them was creating genetically modified cell lines which could produce vaccines for African swine fever virus.
Key players active in the global swine fever vaccine market are EC21 Inc, Ceva, Zoetis Services LLC, Indian Immunologicals Ltd., Merck & Co., Inc., Bioveta, a.s., Komipharm, Boehringer Ingelheim International GmbH and Indian Immunologicals Ltd.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5195
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Swine Fever Vaccine Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Swine Fever Vaccine Industry Impact
Chapter 2 Global Swine Fever Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Swine Fever Vaccine (Volume and Value) by Type
2.3 Global Swine Fever Vaccine (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Swine Fever Vaccine Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Swine Fever Vaccine Market Analysis
Chapter 6 East Asia Swine Fever Vaccine Market Analysis
Chapter 7 Europe Swine Fever Vaccine Market Analysis
Chapter 8 South Asia Swine Fever Vaccine Market Analysis
Chapter 9 Southeast Asia Swine Fever Vaccine Market Analysis
Chapter 10 Middle East Swine Fever Vaccine Market Analysis
Chapter 11 Africa Swine Fever Vaccine Market Analysis
Chapter 12 Oceania Swine Fever Vaccine Market Analysis
Chapter 13 South America Swine Fever Vaccine Market Analysis
Chapter 14 Company Profiles and Key Figures in Swine Fever Vaccine Business
Chapter 15 Global Swine Fever Vaccine Market Forecast (2022-2028)
Chapter 16 Conclusions
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5195
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027